Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
20.3M
-
Number of holders
-
22
-
Total 13F shares, excl. options
-
1.66M
-
Shares change
-
-125K
-
Total reported value, excl. options
-
$8.46M
-
Value change
-
-$814K
-
Put/Call ratio
-
0
-
Number of buys
-
10
-
Number of sells
-
-6
-
Price
-
$5.10
Significant Holders of enVVeno Medical Corp - Common Stock, $0.00001 par value per share (NVNO) as of Q4 2022
26 filings reported holding NVNO - enVVeno Medical Corp - Common Stock, $0.00001 par value per share as of Q4 2022.
enVVeno Medical Corp - Common Stock, $0.00001 par value per share (NVNO) has 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.66M shares
of 20.3M outstanding shares and own 8.19% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (782K shares), VANGUARD GROUP INC (336K shares), KINGDON CAPITAL MANAGEMENT, L.L.C. (219K shares), GEODE CAPITAL MANAGEMENT, LLC (83.1K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (38K shares), BlackRock Inc. (33.8K shares), MORGAN STANLEY (30.4K shares), ARTHUR M. COHEN & ASSOCIATES, LLC (24K shares), STATE STREET CORP (21.5K shares), and DIMENSIONAL FUND ADVISORS LP (21.5K shares).
This table shows the top 22 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.